Summary
The present study was undertaken to explore the role of the Protein Kinase C (PKC) signal transduction system in growth regulation of pituitary adenomas. Primary tumor cultures were plated from fresh surgical tumor specimens. The PKC inhibitors Staurosporine and Tamoxifen were added at varying dosages to the cell cultures. Measurements of cell proliferation were performed by [3H]-thymidine uptake and the [3-(4,5-dimethyl-2-thiazolyl)-2,5diphenyl-2H tetrazolium bromide] (MTT) assay. After a 48 h treatment period, both [3H]-thymidine uptake and absorbance on the MTT assay decreased in a dose-related manner in both the staurosporine and tamoxifen-treated cultures (IC50 of 10 nM and 30 µM respectively). Direct measurement of PKC activity using an in vitro assay revealed very high activity (range of 1465-5708 pmol/min/ mg protein; within the range previously published for malignant glioma specimens) in 12 frozen specimens of pituitary adenomas (9 nonfunctional adenomas, 1 prolactinoma, 1 gonadotrophin-secreting and 1 corticotroph-secreting adenoma). In contrast, PKC activity measured in normal adenohypophysis was comparatively very low. These data indicate that pituitary adenoma cells display high PKC activity and are sensitive to growth inhibition by PKC inhibitors. These data suggest a role for the PKC system in regulating pituitary tumor growth, which may have implications for future therapy of these tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Abbreviations
- FCS:
-
fetal calf serum
- PMA:
-
phorbol-12-myristate-13-acetate (phorbol ester; PKC activator)
- PKC:
-
protein kinase C
- SP:
-
staurosporine (PKC inhibitor)
- TAM:
-
tamoxifen (PKC inhibitor)
References
Alvaro V, Touraine Ph, Vozari RR, Bai-Grenier F, Birman P, Joubert D (1992) Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer 50: 724–730
Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847–7851
Couldwell WT, Antel JP, Apuzzo MEJ, Yong VW (1990) Inhibition of growth of established human glioma lines by modulators of the protein kinase C second messenger system. J Neurosurg 73: 594–600
Couldwell WT, Uhm J, Antel JP, Yong VW (1991) Enhanced protein kinase C activity correlates with the growth rate of malignant human gliomas. Neurosurgery 29: 880–887
Couldwell WT, Antel JP, Yong VW (1992) Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of PKC. Neurosurgery 31: 717 724
Dekker LV, Parker PJ (1994) Protein kinase C— a question of specificity. TIBS 19: 73–77
Drust DS, Martin TFJ (1985) Protein kinase C translocates from cytosol to membrane upon hormone activation: Effects of thyrotropin-releasing hormone in GH3 cells. Biochem Biophys Res Commun 128: 531–537
Emoto N, Ohmura E, Isozaki O, Tsuchima T, Shizume K, Demura H (1991) Phorbol ester, not growth hormone releasing factor, consistently stimulates growth hormone release from somatotroph adenomas in culture. Clin Endocrin 34: 377–382
Fearon CW, Tashjian AH Jr (1985) Thyrotropin-releasing hormone induces redistribution of protein kinase C in GH4C1 rat pituitary cells. J Biol Chem 260: 8366–8371
Fearon CW, Tashjian AH Jr (1987) Ionomycin inhibits thyrotropin-releasing hormone-induced translocation of protein kinase C in GH4C1 pituitary cells. J Biol Chem 262: 9515–9520
Gordeladze JO, Bjoro T, Ostberg BC, Sand O, Torjesen P, Haug E, Gautvik KM (1988) Phorbol esters and thyroliberin have distinct actions regarding stimulation of prolactin secretion and activation of adenylate cyclase in rat anterior pituitary tumor cells (GH4C1). Biochem Pharmacol 37: 3133–3138
Hirota K, Hirota T, Anguilera G, Catt KJ (1985) Hormone-induced redistribution of calcium-activated phospholipiddependent protein kinase in pituitary gonadotrophs. J Biol Chem 260: 3243–3246
Housey GM, Houhnson MD, Hsiao WLW, O’Brian CA, Murphy JP, Kirschmeier P, Weinstein IB (1988) Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343–354
Ikuyama S, Nawata H, Kato KI, Natori S, Ibayashi H (1987) Phorbol ester and phospholipase C-induced growth hormone secretion from pituitary somatotroph adenoma cells in culture: effects of somatostatin, bromocriptine, and pertussis toxin. J Clin Endocrin Met 64: 572–577
Ishizuka T, Ito Y, Murayama M, Miura K, Nagao S, Nozawa Y (1987) Hormone-induced redistribution of protein kinase C in human pituitary adenomas. Clin Chim Acta 170: 351–354
Jin L. Maeda T, Chandler WF, Lloyd RV (1993) Protein kinase C ( PKC) activity and PKC messenger RNAs in human pituitary adenomas. Am J Pathol 142: 569–578
Judd AM, Koike K, Yasumoto T, MacLeod RM (1986) Protein kinase C activators and calcium-mobilizing agents synergistically increase GH, LH, and TSH secretion from anterior pituitary cells. Neuroendocrinology 42: 197
Negro-Vilar A, Lapetina EG (1985) 1,2-Didecanoylglycerol and phorbol 12, 13-dibutyrate enhance anterior pituitary hormone secretion in vitro. Endocrinology 117: 1559
Nishizuka Y (1986) Studies and perspectives on protein kinase C. Science 223: 305–312
Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular recognition. Nature 334: 661–665
O’Brian CA, Ward NE (1989) Biology of the protein kinase C family. Cancer Metastasis Rev 8: 199–214
Ohmura E, Friesen HG (1985) 12-O-Tetradecanoyl phorbol-13acetate stimulates rat growth hormone ( GH) release through different pathways from that of human pancreatic GH-releasingfactors. Endocrinology 116: 728
Persons DA, Wilkison WO, Bell RM, Finn OJ (1988) Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-1 cDNA. Cell 52: 447–458
Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F (1986) Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135: 397–402
Todo T, Buchfelder M, Thierauf P, Fahlbusch R (1993) Immunohistochemical expression of protein kinase C type III in human pituitary adenomas. Neurosurgery 32: 635–642
Todo T, Shitara N, Nakamura H, Takakura K, Ikeda K (1991) Immunohistochemical demonstration of protein kinase C isozymes in human brain tumors. Neurosurgery 29: 399–404
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag
About this paper
Cite this paper
Couldwell, W.T., Law, R.E., Hinton, D.R., Gopalakrishna, R., Yong, V.W., Weiss, M.H. (1996). Protein Kinase C and Growth Regulation of Pituitary Adenomas. In: Fahlbusch, R., Bock, W.J., Brock, M., Buchfelder, M., Klinger, M. (eds) Modern Neurosurgery of Meningiomas and Pituitary Adenomas. Acta Neurochirurgica, vol 65. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9450-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9450-8_8
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-9452-2
Online ISBN: 978-3-7091-9450-8
eBook Packages: Springer Book Archive